Joining a Clinical Trial for Depression or Anxiety: How Screening Works, What Informed Consent Covers and How It Fits Around Residential Care

Some people reach residential mental health treatment after several medications and therapies have not brought enough relief. Around that point, a psychiatrist, a family member or a late-night search often raises the same question: what about a clinical trial? A trial can be a reasonable option to explore, but it runs on its own rules, its own schedule and its own consent process. This guide walks through how trial screening works, what the informed consent document has to cover and what to sort out before admission.

What a Clinical Trial Is and Who Oversees It

The National Institute of Mental Health (NIMH) describes clinical trials as research studies that test new ways to prevent, detect or treat a condition. For depression and anxiety, that can mean a new medication or combination of medications, a device such as a brain stimulation system, or a new form of therapy. Trials take place at medical centers, doctors’ offices and community organizations. NIMH also runs its own studies at the NIH Clinical Center in Bethesda, Maryland, and funds studies at universities and medical centers across the country.

Before a study in the United States can start, an institutional review board (IRB) has to review and approve it. Its job is to weigh risks against potential benefits. NIMH suggests asking any study team directly whether an IRB reviewed the trial. A clear yes is a reasonable baseline before going further.

How Much Time a Study Takes and What It Costs

NIMH’s participant FAQ, checked on October 14, 2026, says the time commitment for its research studies ranges from a day visit of one or more hours, to a single overnight hospital stay, to a week or several months, and that some studies can be done by phone or at home. For studies run at the NIH Clinical Center in Bethesda, NIMH states there is no cost to participate and health insurance is not needed, and that compensation and travel reimbursement are available for some studies.

Studies run elsewhere set their own terms. Some pay participants or cover travel, lodging and meals; others do not. Ask every study team about costs, and treat trial costs and residential treatment costs as two separate questions. If you are planning residential care as well, you can verify your insurance benefits on their own. As of October 14, 2026, the programs this site refers people to do not accept Medi-Cal, Medicare, Medicaid, Ambetter or IEHP, so it is worth confirming coverage early rather than assuming one plan or one budget covers both.

How Trial Screening Works

Every trial has inclusion and exclusion criteria. According to NIMH’s Clinical Research Trials and You fact sheet, these typically cover age, the type and stage of the condition, treatment history and other medical conditions. Eligibility is usually checked first by phone or an online questionnaire, and many studies follow up with an in-person interview.

Screening for a depression or anxiety study tends to include:

• A structured interview about current symptoms and how long they have lasted
• A detailed history of past medications and therapies, including what helped and why each one was stopped
• Questions about other health conditions and everything you currently take, including supplements
• Questions about safety, including current thoughts of suicide. Some studies exclude people at elevated risk right now, because a research study is not designed to be a crisis service.

Not every participant receives the treatment being tested. NIMH notes that some participants may receive a placebo so researchers can compare results. Ask whether the study uses a placebo, how group assignment is decided and whether you will be told which group you were in when the study ends.

What the Informed Consent Document Has to Cover

NIMH explains that the informed consent document should describe the length of the trial, required visits, medications and procedures, expected outcomes, potential benefits and possible risks. The study team reviews it with you and answers questions, and you can decide on the spot or later. Consent documents for medication studies can be long, and it is reasonable to take a copy home and read it over a few days before signing. Two points are easy to miss:

• It is not a contract: Signing confirms you understand the study and how your data will be used. You can stop participating at any time.
• Consent is ongoing: If your circumstances change, such as entering residential treatment, you can revisit your participation with the study team.

Why a Trial and a Residential Stay Can Collide

This is the part that rarely appears in a study flyer. A residential program and a research study each want a say over the same few things, and the friction points are predictable:

• Medication changes: Residential psychiatric teams often adjust medications during a stay, while many trial protocols require a stable regimen or restrict what else you can take.
• Visit schedules: A trial may require on-site visits at set intervals, while residential programs run a structured daily schedule in which off-site appointments need advance arrangement and transportation.
• Overlapping assessments: Both teams use rating scales and interviews, and duplicated or conflicting measurements can muddy both the study data and the treatment plan.
• Eligibility that shifts mid-study: A new diagnosis, a hospitalization or a new medication during residential care may affect whether you can continue in the trial.
• Separate records: Study teams and residential teams generally cannot share information without your written permission, so neither may know what the other is doing unless you sign releases.

None of these is a reason to rule out either option. They are reasons to get both teams talking before admission rather than after. Admissions can move within days while trial screening often takes longer, so call the study team first.

What to Do Before Admission

If you are already enrolled in a trial, or seriously considering one, work through these steps before your admission date:

1. Find the study’s record on ClinicalTrials.gov and write down its NCT number. Save or print the Eligibility Criteria section.
2. Call the study coordinator and ask: “If I enter residential mental health treatment for several weeks, can I stay in the study, and which medication changes would end my participation?”
3. Ask how many on-site visits remain, how far apart they are and whether any can be done by phone or video.
4. Give the NCT number and eligibility criteria to the residential program’s admissions team, and ask whether their psychiatrist will speak with the study team before making any medication changes.
5. Sign release of information forms for both teams so they can coordinate directly.

NIMH recommends telling your own health care provider when you join a trial, since they may want to coordinate with the study team. During a stay, the residential psychiatrist is part of that circle. You can read more about how residential mental health treatment is structured, or compare levels of care on our treatment programs page.

Finding a Study Responsibly

NIMH points to a few main routes: ClinicalTrials.gov, a database of publicly and privately funded studies; NIMH’s own Join a Study listings and FAQ for the Bethesda campus; and ResearchMatch, an NIH-funded registry that connects volunteers with researchers. Be cautious with advertisements that promise results, charge enrollment fees or discourage you from telling your current care team. Legitimate studies describe risks openly, encourage coordination with your providers and should be able to tell you how you will receive the results once the study ends.

When a Trial Is Not the Right Next Step

Research participation is voluntary, and it is often slow: screening, wait lists and travel all take time. When symptoms are making daily life unmanageable, it may make sense to stabilize in a higher level of care first and revisit research later with your care team’s input. If you are unsure which should come first, our team can talk through options with you at 877-883-0780. We can also explain what to ask a program about medication management and outside appointments.

If you or someone you care about is having thoughts of suicide or is in emotional crisis, call or text 988, the Suicide and Crisis Lifeline, any time, day or night. If someone is in immediate danger, call 911 or go to the nearest emergency room. Residential programs and research studies are not emergency services.

Talk Through Your Options

Clinical trials and residential care can each have a place in treating depression or anxiety, and both work best when the people running them know about each other. To talk about residential options, insurance and how to coordinate with a study you are in or considering, call 877-883-0780.

This article is for educational purposes only and is not medical advice. It does not replace an evaluation by a licensed clinician, and it does not recommend any specific study, medication or treatment. Information about NIMH studies was checked against NIMH’s website on October 14, 2026. Study terms and program policies change, so confirm details directly with the study team and treatment program.